Copyright
©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 80-91
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.80
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.80
Figure 3 Controlled attenuation parameter in patients with different body mass indexes.
aP < 0.05 vs S0; cP < 0.05. CAP: Controlled attenuation parameter; BMI: Body mass index.
- Citation: Ni XX, Lian M, Wu HM, Li XY, Sheng L, Bao H, Miao Q, Xiao X, Guo CJ, Li H, Ma X, Hua J. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases. World J Gastroenterol 2021; 27(1): 80-91
- URL: https://www.wjgnet.com/1007-9327/full/v27/i1/80.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i1.80